Mar 22 | Sep 21 | Mar 21 | Sep 20 | Mar 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | € 4.06M | € 1.74M | € 2.36M | € 2.88M | € 2.41M |
Total Assets | € 35.32M | € 35.00M | € 31.98M | € 33.02M | € 32.81M |
Total Debt | € 9.98M | € 7.40M | € 6.15M | € 4.90M | € 5.31M |
Net Debt | € 5.92M | € 5.66M | € 3.79M | € 2.02M | € 2.90M |
Total Liabilities | € 36.08M | € 34.27M | € 32.91M | € 33.31M | € 35.44M |
Stockholders Equity | € -757.00K | € 730.00K | € -934.00K | € -292.00K | € -2.63M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |